Old Web
English
Sign In
Acemap
>
Paper
>
Phase I dose finding study with irinotecan (CPT-11) in cancer patients (pts) with hepatic dysfynction
Phase I dose finding study with irinotecan (CPT-11) in cancer patients (pts) with hepatic dysfynction
1999
Eric Raymond
Laurent Vernillet
Valérie Boige
A Hua
Michel Ducreux
S. Mekhaldi
Christian Jacques
Michel Gatineau
D. Mignard
J.C. Vergniol
Jean-Pierre Armand
Keywords:
Cancer
Cancer research
Pathology
Oncology
Irinotecan
Internal medicine
Medicine
dose finding
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]